Poolbeg Pharma Sign AI Deal With OneThree Biotech For First Human Challenge Trial
Brad Pryde speaks at the Charlton Morris Using Artificial Discovery in Drug Discovery Webinar
Carna & OneThree Biotech Partnership Announcement and Overview
Carna & OneThree Biotech Partnership Announcement This webinar will be announcing the partnership between Carna Biosciences and OneThree Biotech. The OneThree Panel will be available through Carna and provide the opportunity to see drug similarity analysis and toxicity predictions. All material presented in the webinar will be provided afterwards. Submit Questions Below Meet Our Presenters! […]
AACR 2021: Methodologies for Target ID, Drug Repurposing, and Discovering Biomarkers
OneThree Biotech Announces Novel Methodologies for Identifying Targets, Repurposing Drugs, and Discovering Patients’ Biomarkers at AACR Annual Conference 2021 OneThree will be demonstrating how our AI platforms help to identify targets, repurpose drugs, and discover patients’ biomarkers with three posters at the upcoming American Association for Cancer Research (AACR) 2021 conference. These capabilities have been […]
Brad Pryde Speaks at Charlton Morris on Using AI in Drug Discovery
Brad Pryde speaks at the Charlton Morris Using Artificial Discovery in Drug Discovery Webinar
Cory Gilvary Overviews how OneThree Biotech’s Gene Essentiality Module Can Help identify patients for Breast Cancer
Cory Gilvary Overviews how OneThree Biotech’s Gene Essentiality Module Can Help identify patients for Breast Cancer
Brad Pryde presents at BioDataWorld on digital transformation and ai in Drug Discovery
Brad Pryde presents at BioDataWorld on digital transformation and ai in Drug Discovery
Coryander Gilvary speaks at World Drug Safety Congress on Our AI Toxicity Prediction Platform
Coryander Gilvary speaks at World Drug Safety Congress on Our AI Toxicity Prediction Platform